Fredric C. Genter

774 total citations
8 papers, 535 citations indexed

About

Fredric C. Genter is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fredric C. Genter has authored 8 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fredric C. Genter's work include Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). Fredric C. Genter is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). Fredric C. Genter collaborates with scholars based in United States, Argentina and Australia. Fredric C. Genter's co-authors include Steven L. Barriere, Lawrence S. Weisberg, Richard Sweet, Thomas Marbury, Mohamed H. Sayegh, Robin L. Allgren, Richard Lafayette, John D. Conger, Sahinur Rahman and Brenda R.C. Kurnik and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and Journal of Clinical Microbiology.

In The Last Decade

Fredric C. Genter

8 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fredric C. Genter United States 6 220 179 122 87 74 8 535
M. Epstein United States 9 256 1.2× 78 0.4× 52 0.4× 58 0.7× 82 1.1× 13 752
Gaspar Del Rio‐Pertuz United States 10 152 0.7× 103 0.6× 115 0.9× 73 0.8× 201 2.7× 42 586
María Heredia‐Rodríguez Spain 16 52 0.2× 152 0.8× 89 0.7× 93 1.1× 309 4.2× 37 641
Esther Gómez‐Sánchez Spain 16 50 0.2× 102 0.6× 111 0.9× 84 1.0× 251 3.4× 36 609
Jérôme Larché France 7 39 0.2× 202 1.1× 79 0.6× 96 1.1× 377 5.1× 10 628
Ranistha Ratanarat Thailand 14 340 1.5× 55 0.3× 31 0.3× 42 0.5× 171 2.3× 51 608
Céline Monard France 12 119 0.5× 125 0.7× 45 0.4× 43 0.5× 256 3.5× 29 563
Joan Sabater‐Riera Spain 14 76 0.3× 104 0.6× 31 0.3× 41 0.5× 150 2.0× 53 561
Marie‐Louise Trotman United States 7 136 0.6× 71 0.4× 32 0.3× 37 0.4× 51 0.7× 16 380
Elisavet Diamanti Greece 16 112 0.5× 59 0.3× 44 0.4× 51 0.6× 139 1.9× 41 690

Countries citing papers authored by Fredric C. Genter

Since Specialization
Citations

This map shows the geographic impact of Fredric C. Genter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredric C. Genter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredric C. Genter more than expected).

Fields of papers citing papers by Fredric C. Genter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredric C. Genter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredric C. Genter. The network helps show where Fredric C. Genter may publish in the future.

Co-authorship network of co-authors of Fredric C. Genter

This figure shows the co-authorship network connecting the top 25 collaborators of Fredric C. Genter. A scholar is included among the top collaborators of Fredric C. Genter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredric C. Genter. Fredric C. Genter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Barriere, Steven L., Martín E. Stryjewski, G. Ralph Corey, Fredric C. Genter, & Ethan Rubinstein. (2014). Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies. BMC Infectious Diseases. 14(1). 183–183. 32 indexed citations
2.
Sharma‐Kuinkel, Batu K., Sun Hee Ahn, Thomas H. Rude, et al.. (2011). Presence of Genes Encoding Panton-Valentine Leukocidin Is Not the Primary Determinant of Outcome in Patients with Hospital-Acquired Pneumonia Due to Staphylococcus aureus. Journal of Clinical Microbiology. 50(3). 848–856. 34 indexed citations
4.
Shorr, Andrew F., Michael S. Niederman, Marin H. Kollef, et al.. (2008). TELAVANCIN: A NOVEL AGENT FOR VENTILATOR-ASSOCIATED PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS. CHEST Journal. 134(4). 11S–11S. 2 indexed citations
5.
Barriere, Steven L., Fredric C. Genter, Elizabeth Spencer, et al.. (2004). Effects of a New Antibacterial, Telavancin, on Cardiac Repolarization (QTc Interval Duration) in Healthy Subjects. The Journal of Clinical Pharmacology. 44(7). 689–695. 52 indexed citations
6.
Allgren, Robin L., Thomas Marbury, Sahinur Rahman, et al.. (1997). Anaritide in Acute Tubular Necrosis. New England Journal of Medicine. 336(12). 828–834. 279 indexed citations
7.
Roberts, Jared M., Michael Sullivan, Victor F. Froelicher, Fredric C. Genter, & Jonathan Myers. (1984). Predicting oxygen uptake from treadmill testing in normal subjects and coronary artery disease patients. American Heart Journal. 108(6). 1454–1460. 49 indexed citations
8.
Genter, Fredric C. & G.C. Salzman. (1979). A statistical approach to the classification of biological cells from their diffraction patterns.. Journal of Histochemistry & Cytochemistry. 27(1). 268–272. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026